Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CORTADO: hill climbing optimization for cell-type specific marker gene discovery and clustering accuracy improvement.

Bioinformatics advances·2026
Same author

A Comparative Analysis of Explainable AI (XAI) Techniques for Transparent and Reliable Image Classification.

Entropy (Basel, Switzerland)·2026
Same author

The C/EBPα-(PU.1-LOUP) regulatory circuit regulates monocyte/macrophage development and immune functions.

Blood·2026
Same author

Advancing infection profiling under data uncertainty through contagion potential.

PloS one·2025
Same author

GramSeq-DTA: A Grammar-Based Drug-Target Affinity Prediction Approach Fusing Gene Expression Information.

Biomolecules·2025
Same author

Heterogeneous Clustering of Multiomics Data for Breast Cancer Subgroup Classification and Detection.

International journal of molecular sciences·2025
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Oct 20, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K

Relevant and Non-Redundant Feature Selection for Cancer Classification and Subtype Detection.

Pratip Rana1, Phuc Thai1, Thang Dinh1

  • 1Department of Computer Science, Virginia Commonwealth University, Richmond, VA 23284, USA.

Cancers
|September 10, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a novel feature selection algorithm for omics data, identifying key disease-related genes. The method improves classification and subtyping accuracy across various cancers, offering potential for biomarker discovery and precision medicine.

Keywords:
disease classificationfeature subset selectionsubtype detection

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Related Experiment Videos

Last Updated: Oct 20, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Area of Science:

  • Genomics and Bioinformatics
  • Computational Biology
  • Translational Medicine

Background:

  • Identifying significant, non-redundant features from omics data is crucial for biological research.
  • Existing statistical and machine learning methods for gene selection often yield highly co-regulated features, leading to inconsistent performance.

Purpose of the Study:

  • To develop a novel feature selection algorithm for identifying disease-related and non-redundant features from diverse omics datasets.
  • To evaluate the algorithm's performance in disease classification and subtyping across multiple cancer types.

Main Methods:

  • A new feature selection algorithm was developed to extract salient, non-redundant features from omics data.
  • The algorithm was applied to three biological problems: disease-normal classification, multiclass disease classification, and disease subtype detection.
  • Performance was evaluated using metrics such as ROC-AUC, false-positive, and false-negative rates on TCGA cancer datasets.

Main Results:

  • The proposed algorithm outperformed existing gene selection and differential expression methods in binary and multiclass cancer classification.
  • Selected genes enhanced disease subtyping accuracy for four cancer types compared to state-of-the-art approaches.
  • The algorithm demonstrated robust performance across six different cancer datasets from TCGA.

Conclusions:

  • The novel feature reduction method effectively identifies disease-specific biomarkers and relevant features from omics data.
  • This approach supports advancements in precision medicine design and disease subtyping.
  • The algorithm offers a valuable tool for biologists and researchers working with complex omics datasets.